Haemostatic and inflammatory responses to blood flow-restricted exercise in patients with ischaemic heart disease: a pilot study. 2013

Haruhiko Madarame, and Miwa Kurano, and Kazuya Fukumura, and Taira Fukuda, and Toshiaki Nakajima
Department of Ischemic Circulatory Physiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. madarame@idaten.c.u-tokyo.ac.jp

Low-intensity resistance exercise can effectively induce muscle hypertrophy and increases in strength when combined with moderate blood flow restriction (BFR). As this type of exercise does not require lifting heavy weights, it might be a feasible method of cardiac rehabilitation, in which resistance exercise has been recommended to be included. Although previous studies with healthy subjects showed relative safety of BFR exercise, we cannot exclude the possibility of unfavourable effects in patients with cardiovascular disease. We therefore aimed to investigate haemostatic and inflammatory responses to BFR exercise in patients with ischaemic heart disease (IHD). Nine stable patients with IHD who were not taking anticoagulant drugs performed four sets of knee extension exercise at an intensity of 20% one-repetition maximum (1RM) either with or without BFR. Blood samples were taken before, immediately after and 1 h after the exercise session and analysed for noradrenaline, D-dimer, fibrinogen/fibrin degradation products (FDP) and high-sensitive C-reactive protein (hsCRP). Plasma noradrenaline concentration increased after the exercise, and the increase was significantly larger after the exercise with BFR than without BFR. On the other hand, increases in concentrations of plasma D-dimer and serum hsCRP were independent of the condition. However, increases in D-dimer and hsCRP were no longer observed after plasma volume correction, suggesting that hemoconcentration was responsible for these increases. Plasma FDP concentration did not change after the exercise. These results suggest that applying BFR during low-intensity resistance exercise does not affect exercise-induced haemostatic and inflammatory responses in stable IHD patients.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D010865 Pilot Projects Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Pilot Studies,Pilot Study,Pilot Project,Project, Pilot,Projects, Pilot,Studies, Pilot,Study, Pilot
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D005260 Female Females
D005338 Fibrin Fibrinogen Degradation Products Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. FDP and their complexes profoundly impair the hemostatic process and are a major cause of hemorrhage in intravascular coagulation and fibrinolysis. Antithrombin VI,Fibrin Degradation Product,Fibrin Degradation Products,Fibrin Fibrinogen Split Products,Degradation Product, Fibrin,Degradation Products, Fibrin,Product, Fibrin Degradation
D006487 Hemostasis The process which spontaneously arrests the flow of BLOOD from vessels carrying blood under pressure. It is accomplished by contraction of the vessels, adhesion and aggregation of formed blood elements (eg. ERYTHROCYTE AGGREGATION), and the process of BLOOD COAGULATION. Hemostases

Related Publications

Haruhiko Madarame, and Miwa Kurano, and Kazuya Fukumura, and Taira Fukuda, and Toshiaki Nakajima
January 1979, Thrombosis research,
Haruhiko Madarame, and Miwa Kurano, and Kazuya Fukumura, and Taira Fukuda, and Toshiaki Nakajima
January 1984, Advances in experimental medicine and biology,
Haruhiko Madarame, and Miwa Kurano, and Kazuya Fukumura, and Taira Fukuda, and Toshiaki Nakajima
July 1981, Lancet (London, England),
Haruhiko Madarame, and Miwa Kurano, and Kazuya Fukumura, and Taira Fukuda, and Toshiaki Nakajima
August 2014, Medicine and science in sports and exercise,
Haruhiko Madarame, and Miwa Kurano, and Kazuya Fukumura, and Taira Fukuda, and Toshiaki Nakajima
May 1985, British heart journal,
Haruhiko Madarame, and Miwa Kurano, and Kazuya Fukumura, and Taira Fukuda, and Toshiaki Nakajima
March 2020, American journal of physiology. Renal physiology,
Haruhiko Madarame, and Miwa Kurano, and Kazuya Fukumura, and Taira Fukuda, and Toshiaki Nakajima
March 2015, Journal of sports science & medicine,
Haruhiko Madarame, and Miwa Kurano, and Kazuya Fukumura, and Taira Fukuda, and Toshiaki Nakajima
October 2023, Acta physiologica (Oxford, England),
Haruhiko Madarame, and Miwa Kurano, and Kazuya Fukumura, and Taira Fukuda, and Toshiaki Nakajima
January 1999, Drugs,
Haruhiko Madarame, and Miwa Kurano, and Kazuya Fukumura, and Taira Fukuda, and Toshiaki Nakajima
August 2013, Journal of strength and conditioning research,
Copied contents to your clipboard!